Gene · 50652
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Application of Non-Coding RNAs as Biomarkers, Therapies, and Novel Vaccines in Diseases. | Int J Mol Sci | 2025 | 40243658 | PubTator, text mining | PubMed |
| Performance of PCA3 and TMPRSS2:ERG Within the Prostate Cancer Prevention Trial Risk Calculator Version 2 in a Lithuanian Cohort. | Res Rep Urol | 2025 | 40176971 | PubTator, text mining | PubMed |
| Serum and Urine Biomarkers for Prostate Cancer: A Mini Review. | Mymensingh Med J | 2025 | 40160085 | PubTator, text mining | PubMed |
| New biomarkers and multiplex tests for diagnosis of aggressive prostate cancer and therapy management. | Front Oncol | 2025 | 40115018 | PubTator, text mining | PubMed |
| Integrated Device for Cancer Nucleic Acid Biomarker Detection at Body Temperature. | Micromachines (Basel) | 2025 | 40047709 | PubTator, text mining | PubMed |
| Differentiation of high risk prostate cancer with a facile urinary exosome detection workflow. | iScience | 2025 | 39995874 | PubTator, text mining | PubMed |
| Usefulness of urinary biomarker-based risk score and multiparametric MRI for clinically significant prostate cancer detection in biopsy-naïve patients. | Abdom Radiol (NY) | 2025 | 39862284 | PubTator, text mining | PubMed |
| Liquid-Based Diagnostic Panels for Prostate Cancer: The Synergistic Role of Soluble PD-L1, PD-1, and mRNA Biomarkers. | Int J Mol Sci | 2025 | 39859417 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways. | Funct Integr Genomics | 2025 | 39821470 | PubTator, text mining | PubMed |
| A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear. | J Thromb Haemost | 2025 | 39798927 | PubTator, text mining | PubMed |
| Glutaraldehyde functionalized reduced graphene oxide based resistive sensors for detection of PCA3. | J Mater Chem B | 2025 | 39791316 | PubTator, text mining | PubMed |
| Potential value of Prostate Cancer Antigen 3 score in prediction of final cancer pathology parameters in radical prostatectomy patients. | Urologia | 2025 | 39668680 | PubTator, text mining | PubMed |
| Differentially Expressed Blood ARLNC1 in Combination with PCA3/PSA has Reassuring Clinical Applications in the Early Diagnosis of Prostate Cancer in Iranians: A pilot study. | Urol J | 2025 | 39164912 | PubTator, text mining | PubMed |
| Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study. | World J Surg Oncol | 2024 | 39736725 | PubTator, text mining | PubMed |
| Exploring the Role of Long Non-Coding RNAs in Predicting Outcomes for Hepatitis B Patients. | Asian Pac J Cancer Prev | 2024 | 39733424 | PubTator, text mining | PubMed |
| Adult dietary patterns and their association with iodine nutrition levels and thyroid function: a cross-sectional study. | Public Health Nutr | 2024 | 39600224 | PubTator, text mining | PubMed |
| Exploring Plasmonic Standalone Surface-Enhanced Raman Scattering Nanoprobes for Multifaceted Applications in Biomedical, Food, and Environmental Fields. | Nanomaterials (Basel) | 2024 | 39591079 | PubTator, text mining | PubMed |
| Gold-Graphene Quantum Dot Hybrid Nanoparticle for Smart Diagnostics of Prostate Cancer. | Biosensors (Basel) | 2024 | 39589993 | PubTator, text mining | PubMed |
| Advancements in Biomarkers of Prostate Cancer: A Review. | Technol Cancer Res Treat | 2024 | 39440372 | PubTator, text mining | PubMed |
| The continued pursuit of new strategies and new technologies. | Asian J Androl | 2024 | 39422628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50652/papers?page=4